[company_age]2.0[/company_age][employees]11-50 employees[/employees][description]GENESIS Tech Transfer Boost is an investment vehicle created in 2022 and managed by the consultancy GENESIS Biomed. Its objective is to identify and invest in early-stage biomedical projects from the ITEMAS Platform and the healthcare environment. The founding partners are GENESIS Biomed, FI Group, and Crowd4Ventures, committing a total of €1 million for the next four years. Additionally, the possibility of increasing the size of the vehicle by incorporating new partners is not ruled out. The creation of the investment vehicle will allow the identification of projects in an ecosystem as solid as the ITEMAS Platform. In addition, they will be accompanied and managed from the earliest stages of the project, streamlining their arrival on the market. The vehicle is positioned in the field of incubation, with a target on early-stage projects from the ITEMAS network and the country's health centers. Being agnostic in the field of biomedicine, investing in those projects that have a fit with the life cycle of the vehicle, both at the medtech, diagnostic, biotech, and digital levels. Tickets of between €25,000 and €100,000 will be invested according to the nature of each project and its needs. The possibility of investing even in a pre-constitutive phase of the projects is contemplated. The objective is to carry out the first investment before the summer of 2022. GENESIS Biomed has validated the value proposition and investment model of the vehicle through a first vehicle, GENESIS Ventures I, which has invested in 13 projects and has a portfolio revaluation to date with a multiplier of x3.37.[/description][ps]Investment in early-stage biomedical projects.[/ps]